NDC 69238-1834-01 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69238-1834
- Requested NDC
- 69238-1834-01
- Package NDCs from labels
- 69238-1834-1, 69238-1834-7, 69238-1834-01
- Manufacturer
- NCS HealthCare of KY, LLC dba Vangard Labs
- Effective date
- 2026-06-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - NCS HealthCare of KY, LLC dba Vangard Labs | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-06-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium Tablets, USP | RPK Pharmaceuticals, Inc. | 2024-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals NY LLC | 2024-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium Tablets, USP | PD-Rx Pharmaceuticals, Inc. | 2021-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium Tablets, USP | NuCare Pharmaceuticals,Inc. | 2021-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium Tablets, USP | NuCare Pharmaceuticals,Inc. | 2021-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2021-01-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - Bryant Ranch Prepack | Bryant Ranch Prepack | 2020-09-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium Tablets, USP | Preferred Pharmaceuticals Inc. | 2020-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - Proficient Rx LP | Proficient Rx LP | 2020-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2019-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 69238-1834-1 | 2024-02-08 | Levothyroxine Sodium Tablets, USP |
| 69238-1834-7 | 2024-02-08 | Levothyroxine Sodium Tablets, USP |
| 69238-1834-1 | 2024-01-30 | Levothyroxine Sodium Tablets, USP |
| 69238-1834-7 | 2024-01-30 | Levothyroxine Sodium Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-1834-1 | Levothyroxine Sodium | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 10 | |
| 69238-1834-7 | Levothyroxine Sodium | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-1834 | LEVOTHYROXINE SODIUM TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 10 | Current NDC, Legacy NDC, 2 package rows | 20241208_fca88c97-5cd4-4834-ba87-deb5bd637788.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69238-1834-1 | EA - Each | 69238-1834 | 3a68bca2-04a7-4d89-a161-31002e34a8d7 | 1 | 2018-12-13 |
| 69238-1834-7 | EA - Each | 69238-1834 | ff7c2539-f0eb-40e4-9355-1c8ba340ac98 | 1 | 2018-12-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b45189d2-529b-4d5a-89a9-697bcd61fdb4 | 2026-09-17 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 5ae839f4-bca9-4601-ba80-f2018b9142e4 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e9a9b3c8-2ebf-422f-a60b-8d2bd806f3f6 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 1cacd07a-6fcc-4cdb-aee8-7a62493eb579 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 0266d5d9-edb3-4d0d-ab24-5d1d65f7e501 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2622a029-5f4f-4675-9e3d-66e7aa12ce9d | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Alvogen, Inc. | 4ddcaec1-a58f-340b-9bc1-bbe048b8c885 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6f4bc4be-17a7-4273-a8d9-a1ff036dea0e | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 9ad82faf-3734-42a1-befe-f6197b27f534 | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 817656c7-3b6d-4f94-83e6-dec9e0d35c84 | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | bc9385d0-5c67-4bde-94da-e621347e2cba | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 4c903249-69e9-4168-a9d1-22e6c2c1eb22 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6f25cbb3-0358-4778-b8f0-f76479a2dcc5 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 7fd988be-ab3d-406d-a55d-1e5a8a2101cc | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6108759a-783e-42ca-b078-6a3cd84ce901 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 13e03769-9a4f-497f-9afa-95bf525090b3 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | d8bdea29-fc63-49b4-bc35-9029ec7b1bb9 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| BMNP Silicea | SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a58454f-aed6-24ba-e063-6294a90a47fb | 2026-08-31 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.